We evaluated relative mRNA expression levels of HDAC1 and HDAC2 across different grades of glioma using the The Cancer Genome Atlas (TCGA), Chinese Glioma Genome Atlas (CGGA), and Repository of Molecular Brain Neoplasia Data (REMBRANDT) databases (12, 28, 29). This evidence concerns the gene HDAC2 and central nervous system cancer.